Marketing News – MarketingTools365 – Mktg News – Marketing Tools 365 – //// Business Marketing news and Mktg News : Global Erectile Dysfunction Drugs Market 2019-2023| Presence of Novel Drug Formulations in the Late Stages of Development to Boost Growth| Technavio :
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Research?src=hash" target="_blank"gt;#Researchlt;/agt;–The global erectile dysfunction (ED) drugs market is expected to post a
CAGR of over (4)% during the period 2019-2023. The market is expected to
decelerate on a year-on-year basis during the forecast period.
With the increasing health consciousness across the globe, there has
been a significant increase in healthcare spending for sexual wellness.
The physical and hormonal changes in the body associated with aging,
lead to a decrease in libido, a side-effect of ED. Hence, ED is more
common among the geriatric population, and there has been a rise in the
demand for ED drugs among this population. Moreover, the therapeutic
benefits of these drugs, such as longer half-life in the body and the
ease of administration even via the sublingual route, are expected to
drive the adoption of ED drugs. The rising cyberpornography and the
increasing number of advertisements for the treatment of ED are also
expected to drive the growth of the market during the forecast period.
As per Technavio, the presence of novel drug formulations in the late
stages of development will have a positive impact on the market and
contribute to its growth significantly over the forecast period. This global
erectile dysfunction drugs market research report also
analyzes other important trends and market drivers that will affect
market growth during 2019-2023.
Global erectile dysfunction drugs market:
Presence of novel drug formulations in the late stages of development
Currently, the market is dominated by the oral formulations of the drugs
used for the treatment of ED. However, during the forecast period,
several novel formulations of ED drugs, such as topical gels,
injectables, and suppositories, are expected to emerge in the market.
These novel formulations will attract a large number of patients, owing
to their therapeutic benefits. They are also expected to widen the scope
of treatment for ED.
“Apart from the presence of novel drug formulations in the late
stages of development, the rising awareness of ED is increasing across
the globe as it is an underdiagnosed and undertreated disorder. To
overcome the lack of awareness regarding the conditions that lead to ED,
several organizations, healthcare agencies, and government bodies are
also focusing on improving the quality of life of the patients, which
will boost the growth of the global erectile dysfunction drugs market,” says
a senior analyst at Technavio.
Global erectile dysfunction drugs market:
This market research report segments the global erectile dysfunction
drugs market by product (topical drugs and oral drugs) and geographical
regions (North America, Europe, Asia, and ROW).
The North American region led the market in 2018, followed by Europe,
Asia, and ROW, respectively. However, this region will exhibit a slow
growth rate as compared to the rest of the regions in the forecast
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
Media & Marketing Executive
+1 844 364 1100
UK: +44 203 893 3200
. From Business Wire – Marketingtools365(COMM) – ATOM http://bit.ly/2DcVMQ7 Source : Global Erectile Dysfunction Drugs Market 2019-2023| Presence of Novel Drug Formulations in the Late Stages of Development to Boost Growth| Technavio – http://bit.ly/2DcVMQ7